IL101248A - History of indole, their preparation and the pharmaceutical preparations containing them - Google Patents

History of indole, their preparation and the pharmaceutical preparations containing them

Info

Publication number
IL101248A
IL101248A IL10124892A IL10124892A IL101248A IL 101248 A IL101248 A IL 101248A IL 10124892 A IL10124892 A IL 10124892A IL 10124892 A IL10124892 A IL 10124892A IL 101248 A IL101248 A IL 101248A
Authority
IL
Israel
Prior art keywords
indolyl
methyl
urea
diisopropylphenyl
alkyl
Prior art date
Application number
IL10124892A
Other languages
English (en)
Hebrew (he)
Other versions
IL101248A0 (en
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of IL101248A0 publication Critical patent/IL101248A0/xx
Publication of IL101248A publication Critical patent/IL101248A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL10124892A 1991-03-26 1992-03-16 History of indole, their preparation and the pharmaceutical preparations containing them IL101248A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9103618A FR2674522B1 (fr) 1991-03-26 1991-03-26 Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.

Publications (2)

Publication Number Publication Date
IL101248A0 IL101248A0 (en) 1992-11-15
IL101248A true IL101248A (en) 1996-12-05

Family

ID=9411107

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10124892A IL101248A (en) 1991-03-26 1992-03-16 History of indole, their preparation and the pharmaceutical preparations containing them

Country Status (25)

Country Link
US (1) US5219859A (sh)
EP (1) EP0506532B1 (sh)
JP (1) JPH0597802A (sh)
KR (1) KR950007753B1 (sh)
AT (1) ATE111078T1 (sh)
AU (1) AU658609B2 (sh)
CA (1) CA2063170A1 (sh)
CS (1) CS89592A3 (sh)
DE (1) DE69200378T2 (sh)
DK (1) DK0506532T3 (sh)
ES (1) ES2064149T3 (sh)
FR (1) FR2674522B1 (sh)
HU (1) HUT65489A (sh)
IE (1) IE65366B1 (sh)
IL (1) IL101248A (sh)
MA (1) MA22474A1 (sh)
MX (1) MX9201365A (sh)
NO (1) NO178260C (sh)
NZ (1) NZ242078A (sh)
OA (1) OA09573A (sh)
RU (1) RU2074179C1 (sh)
SI (1) SI9210305A (sh)
TN (1) TNSN92022A1 (sh)
YU (1) YU30592A (sh)
ZA (1) ZA922163B (sh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687402B1 (fr) * 1992-02-14 1995-06-30 Lipha Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
WO1993024458A1 (en) * 1992-05-28 1993-12-09 Pfizer Inc. New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)
NZ250916A (en) * 1993-02-27 1995-08-28 Nihon Nohyaku Co Ltd N-heteroaryl-n'-phenylureas, their use as acat inhibitors
IL109568A0 (en) * 1993-05-19 1994-08-26 Fujisawa Pharmaceutical Co Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4401893A1 (de) * 1994-01-24 1995-07-27 Bayer Ag Substituierte Arylharnstoffe
JP3720395B2 (ja) 1994-09-20 2005-11-24 京都薬品工業株式会社 新規ヘテロ環誘導体、その製造方法およびその医薬用途
DE69523182T2 (de) * 1995-06-06 2002-02-07 Pfizer Substituierte n-(indol-2-carbonyl)-glycinamide und derivate als glycogen phosphorylase inhibitoren
MX9709874A (es) 1995-06-06 1998-03-31 Pfizer N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN.
KR100241643B1 (ko) * 1995-06-06 2000-03-02 디. 제이. 우드 당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
AU679887B2 (en) * 1995-09-11 1997-07-10 Nihon Nohyaku Co., Ltd. Azole derivatives, their use, production and usage
DE69617731T2 (de) * 1995-10-05 2002-08-08 Kyoto Pharmaceutical Industries, Ltd. Neue heterozyklische derivate und ihre medizinische anwendung
EP0773218A1 (en) * 1995-11-13 1997-05-14 Mitsubishi Chemical Corporation N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis
FR2763334A1 (fr) * 1997-05-13 1998-11-20 Lipha Derives anthraniliques
CA2304974C (en) * 1997-12-16 2005-10-25 Warner-Lambert Company 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
CN1210268C (zh) * 1997-12-16 2005-07-13 沃尼尔·朗伯公司 ((环)烷基取代的)－γ－氨基丁酸衍生物(=GABA类似物),其制备和在治疗神经病中的用途
US6545022B1 (en) * 1997-12-16 2003-04-08 Pfizer Inc. 4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
SK282727B6 (sk) 1997-12-19 2002-11-06 Slovakofarma, A. S. 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
WO2002048150A2 (en) 2000-11-02 2002-06-20 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
BR0309764A (pt) * 2002-05-03 2005-02-15 Warner Lambert Co Antagonistas de bombesina
EP1541553B1 (en) * 2002-07-17 2010-06-02 Kyoto Pharmaceutical Industries, Ltd. Indoline compound and medicinal use thereof
US7595403B2 (en) 2003-04-01 2009-09-29 Eli Lilly And Company Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
WO2007062998A1 (en) 2005-11-30 2007-06-07 F. Hoffmann-La Roche Ag 3-amino-2-arylpropyl azaindoles and uses thereof
BRPI0619263A2 (pt) 2005-11-30 2011-09-27 Hoffmann La Roche indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis
RU2361581C2 (ru) * 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
SK287385B6 (sk) 2007-11-27 2010-08-09 Hameln-Rds, A. S. 1,3-Disubstituované močoviny, spôsob ich prípravy a použitia
CN104628621A (zh) * 2015-01-22 2015-05-20 湖南华腾制药有限公司 一种氟取代吲哚衍生物的制备方法
KR102646172B1 (ko) 2017-06-26 2024-03-13 루넬라 바이오테크 인코포레이티드 미토케토신: 암 세포에서 케톤 대사를 표적화하는 미토콘드리아-기반의 치료제
WO2020176599A1 (en) 2019-02-27 2020-09-03 The Regents Of The University Of California Azepino-indoles and other heterocycles for treating brain disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151505A (en) * 1979-05-14 1980-11-26 Kuraray Co Ltd Indole agricultural and horticultural fungicide
ZA88498B (en) * 1987-02-02 1989-10-25 Lilly Co Eli Alkylmelatonins
EP0375133A1 (en) * 1988-11-14 1990-06-27 The Upjohn Company Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
PH30133A (en) * 1989-09-07 1997-01-21 Abbott Lab Indole-, benzofuran-, and benzothiophene-containing lipoxygenase inhibiting compounds
MX22406A (es) * 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).
ATE130002T1 (de) * 1990-08-13 1995-11-15 Hoechst Roussel Pharma 1-(pyridinylalkyl)-1h-indole, -indoline und analoge.
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993005020A1 (en) * 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase

Also Published As

Publication number Publication date
KR950007753B1 (ko) 1995-07-14
CA2063170A1 (en) 1992-09-27
OA09573A (fr) 1993-01-31
TNSN92022A1 (fr) 1993-06-08
ATE111078T1 (de) 1994-09-15
IL101248A0 (en) 1992-11-15
DK0506532T3 (da) 1995-02-20
HUT65489A (en) 1994-06-28
NO921141D0 (no) 1992-03-24
DE69200378T2 (de) 1995-03-09
HU9200997D0 (en) 1992-05-28
ZA922163B (en) 1993-09-27
FR2674522B1 (fr) 1993-07-16
IE920937A1 (en) 1992-10-07
NO178260C (no) 1996-02-21
US5219859A (en) 1993-06-15
DE69200378D1 (de) 1994-10-13
YU30592A (sh) 1994-12-28
EP0506532A1 (fr) 1992-09-30
RU2074179C1 (ru) 1997-02-27
JPH0597802A (ja) 1993-04-20
IE65366B1 (en) 1995-10-18
CS89592A3 (en) 1992-10-14
MX9201365A (es) 1992-10-01
SI9210305A (en) 1996-02-29
FR2674522A1 (fr) 1992-10-02
EP0506532B1 (fr) 1994-09-07
KR920018022A (ko) 1992-10-21
AU1309492A (en) 1992-10-01
NO921141L (no) 1992-09-28
NZ242078A (en) 1994-10-26
MA22474A1 (fr) 1992-10-01
ES2064149T3 (es) 1995-01-16
AU658609B2 (en) 1995-04-27
NO178260B (no) 1995-11-13

Similar Documents

Publication Publication Date Title
IL101248A (en) History of indole, their preparation and the pharmaceutical preparations containing them
US5338849A (en) Azaindoles, preparation processes and medicinal products containing them
KR100359393B1 (ko) 5-ht1a 길항제로서의 피페라진유도체 및 이의 제조방법
CA2559733C (en) Inhibitors of histone deacetylase
KR101441146B1 (ko) Ｎｐｙ ｙ5 수용체 길항 작용을 갖는 아민 유도체
AU2006239545A1 (en) Phenylacetylene derivatives having MGLUR5 receptor affinity
JP2008545686A (ja) ５ｈｔ６受容体を調節する新規な８−スルホニルアミノ−３アミノ置換クロマンまたはテトラヒドロナフタレン誘導体
JP2012236848A (ja) 脂肪酸アミドヒドロラーゼのモジュレーターとしてのピペラジニルおよびピペリジニル尿素
NZ230493A (en) N-substituted nicotinamide derivatives and pharmaceutical compositions
JP2007509930A (ja) アシル尿素およびスルホニル尿素が結合したヒドロキサマート
DK162629B (da) 2-substituerede 1-aralkyl-imidazoler og farmaceutiske midler der indeholder disse, anvendelse heraf til fremstilling af farmaceutiske midler samt fremgangsmaade til fremstilling heraf
JP4503549B2 (ja) インダニル−ピペラジン化合物、その製造方法及びこれらを含む医薬組成物
WO2004048383A1 (en) Mixed lineage kinase modulators
IE57057B1 (en) Carboxamides,process for their preparation and pharmaceutical preparations containing them
JP2006508090A (ja) 新規β−アゴニスト、それらの製造方法及び医薬組成物としてのそれらの使用
AU2003220122A1 (en) Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
NZ286340A (en) Amides of 2-(4-indolyl piperazia-1-yl)-1-ph-enyl (and bemzyl)ethyl amine derivatives with various (cyclo) alkane carboxylic acids; pharmaceutical compositions
KR100248643B1 (ko) 아릴 및 헤테로아릴 알콕시나프탈렌 유도체
MXPA06003382A (es) Derivado de carboxamida de tipo amida.
AU682428B2 (en) New substituted sulphonamides, a process for their preparation and pharmaceutical compositions containing them
US6281215B1 (en) 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications
JPS62226959A (ja) ピリジン誘導体、それらの製法および向意識、抗うつ、抗パーキンソン病剤
NO132690B (sh)

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void